385108009: Conventional release cutaneous solution (dose form)

SNOMED CT Concept\Qualifier value (qualifier value)\Pharmaceutical dose form (dose form)\Cutaneous dose form\Cutaneous solution

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1479370017 Cutaneous solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3558864015 Conventional release cutaneous solution (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3558865019 Conventional release cutaneous solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

16701000188114 solution pour application cutanée fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous solution	Is a	forme pharmaceutique pour usage transdermique et/ou cutané	false	Inferred relationship	Some
Cutaneous solution	Is a	Drug solution	false	Inferred relationship	Some
Cutaneous solution	Is a	Cutaneous dose form	true	Inferred relationship	Some
Cutaneous solution	Has dose form administration method (attribute)	A method of administration of a dose form by placing or spreading on a body surface.	true	Inferred relationship	Some
Cutaneous solution	Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility.	An intended site for a dose form that is for administration by application to the skin, cutaneous wounds, nails or hair.	true	Inferred relationship	Some
Cutaneous solution	Has dose form release characteristic (attribute)	A release characteristic where a dose form displays a rate and time of release of the active substance(s) in the dose form based on their intrinsic properties.	true	Inferred relationship	Some
Cutaneous solution	Has basic dose form (attribute)	Solution	true	Inferred relationship	Some
Cutaneous solution	Has dose form transformation (attribute)	No transformation	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely amorolfine hydrochloride 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	False	Cutaneous solution	Inferred relationship	Some
Lactic acid (as ammonium lactate) 167 mg/mL and salicylic acid 167 mg/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Minoxidil 50 mg/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Amorolfine (as amorolfine hydrochloride) 50 mg/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Cetrimide 5 mg/mL and chlorhexidine gluconate 500 microgram/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Minoxidil 100 mg/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Minoxidil 20 mg/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Product containing precisely chloroxylenol 48 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Iodine 50 mg/mL and potassium iodide 100 mg/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Salicylic acid 50 mg/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Product containing precisely povidone iodine 75 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Product containing precisely iodine 25 milligram/1 milliliter and potassium iodide 25 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Product containing precisely permethrin 10 milligram/1 gram conventional release cutaneous solution (clinical drug)	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Aluminum chloride 350 mg/mL and isopropyl alcohol 325 mg/mL cutaneous solution	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some
Product containing precisely fluorouracil 5 milligram/1 gram and salicylic acid 100 milligram/1 gram conventional release cutaneous solution (clinical drug)	Has manufactured dose form	True	Cutaneous solution	Inferred relationship	Some

Start Page 2 of 2

This concept is not in any reference sets